REAX
Overvalued by 24.5% based on the discounted cash flow analysis.
Market cap | $1.12 Billion |
---|---|
Enterprise Value | $1.13 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.15 |
Beta | 1.5 |
Outstanding Shares | 189,046,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -32.64 |
---|---|
PEG | 47.21 |
Price to Sales | 0.56 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 0.8 |
Enterprise Value to EBIT | -76.34 |
Enterprise Value to Net Income | -74 |
Total Debt to Enterprise | 0.03 |
Debt to Equity | 0.92 |
No data
No data